Overview

Description

  • NatureSynthetic
  • Amino Acid Sequence
    • SpeciesHuman
    • SequenceC-QYKRDKFKKTKYGSQ
    • Amino acids796 to 810

Associated products

Specifications

Our Abpromise guarantee covers the use of ab45651 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Blocking - Blocking peptide for Anti-RASA3 antibody (ab31286)

  • FormLiquid
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

General Info

  • Alternative names
    • GAP III
    • GAP1(IP4BP)
    • GAP1IP4BP
    • GAPIII
    • GTPase activating protein 1 family
    • GTPase activating protein III
    • Inositol 1 3 4 5 tetrakisphosphate binding protein
    • Inositol 1345 tetrakisphosphate binding protein
    • Ins P4 binding protein
    • Ins P4-binding protein
    • Ins(1 3 4 5)P4 binding protein
    • Ins(1345)P4 binding protein
    • MGC46517
    • MGC47588
    • Ras GTPase activating protein 3
    • Ras GTPase-activating protein 3
    • RAS p21 protein activator 3
    • RASA 3
    • RASA3
    • RASA3_HUMAN
    see all
  • FunctionInhibitory regulator of the Ras-cyclic AMP pathway. Binds inositol tetrakisphosphate (IP4) with high affinity. Might be a specific IP4 receptor.
  • Sequence similaritiesContains 1 Btk-type zinc finger.
    Contains 2 C2 domains.
    Contains 1 PH domain.
    Contains 1 Ras-GAP domain.
  • Cellular localizationCell membrane.
  • Information by UniProt

References for RASA3 peptide (796-810) (ab45651)

ab45651 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab45651.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"